Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy (Q43152628)

14 November 2017

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy (English)

1 reference

14 November 2017

2

1 reference

14 November 2017

6

1 reference

14 November 2017

14

1 reference

14 November 2017

16

1 reference

14 November 2017

Cristina Guilera

3

0 references

Stéphane Fourcade

Stéphane Fourcade

1

0 references

Stephan Kemp

Stephan Kemp

11

0 references

Jean-Louis Mandel

Jean Louis Mandel

12

0 references

Ronald J A Wanders

10

Ronald Wanders

1 reference

14 November 2017

15

Patrick Aubourg

1 reference

14 November 2017

7

Manuel Portero-Otín

1 reference

14 November 2017

9

Nathalie Cartier

1 reference

14 November 2017

Eric Hahnen

4

1 reference

14 November 2017

Lars Brichta

5

1 reference

14 November 2017

Georges Dacremont

8

1 reference

14 November 2017

Brunhilde Wirth

13

1 reference

14 November 2017

23 February 2010

1 reference

14 November 2017

Human Molecular Genetics

1 reference

14 November 2017

19

1 reference

14 November 2017

2005-2014

1 reference

14 November 2017

10

1 reference

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

14 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

PXA1, a possible Saccharomyces cerevisiae ortholog of the human adrenoleukodystrophy gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Pharmacological strategies for muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Human ATP-binding cassette (ABC) transporter family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

The role of histone acetylation in SMN gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Phase II open label study of valproic acid in spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Valproic acid treatment in six patients with spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxama

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Adreno-leukodystrophy: oxidative stress of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Maillard reaction products in tissue proteins: new products and new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Molecular Species of Phosphatidylcholine Containing Very Long Chain Fatty Acids in Human Brain: Enrichment in X-Linked Adrenoleukodystrophy Brain and Diseases of Peroxisome Biogenesis Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Comparison of valproate concentrations in human plasma, CSF and brain tissue after administration of different formulations of valproate or valpromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

A simple method for organotypic cultures of nervous tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Fatty acid elongases in mammals: their regulation and roles in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Elongation of long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Steroid hormones control circadian Elovl3 expression in mouse liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Cytoprotection by lithium and valproate varies between cell types and cellular stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Carnitine in the treatment of valproic acid-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ082

21 January 2018

Identifiers

DOI

10.1093/HMG/DDQ082

1 reference

14 November 2017

1 reference